About
Approach
Investment Model
Investment Scope
Our approach
Team
Managing Partner
Partners
Our team
Portfolio
News
Connect
Pages
Pages
Home
About
Blog
Blog Post
Contact
Portfolio
Investors
Investor Single
Shop
Shop Single
Utility Pages
Start Here
Style Guide
404 Not Found
Password Protected
Licenses
Changelog
Browse More Templates
Domain Therapeutics Doses First Patients in Phase I / II Trial of DT-7012 Targeting CCR8 in Solid Tumors
Article Date
October 28, 2025
This article is featured on another website.
Go to article
Related posts
Browse all articles
April 29, 2026
The Next Frontier in Newborn Screening and Why It Matters for Canavan Families
April 29, 2026
The Next Frontier in Newborn Screening and Why It Matters for Canavan Families
April 23, 2026
CRM Trial Connect 2026 Kuala Lumpur: Where to Find HiRO and What’s New
HiRO Attending CRM Trial Connect 2026 in Kuala Lumpur HiRO will be attending CRM Trial…
April 23, 2026
CRM Trial Connect 2026 Kuala Lumpur: Where to Find HiRO and What’s New
HiRO Attending CRM Trial Connect 2026 in Kuala Lumpur HiRO will be attending CRM Trial…